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Abstract
 
Receptor-stimulated generation of reactive oxygen species (ROS) has been shown to regulate
signal transduction, and previous studies have suggested that T cell receptor (TCR) signals may
involve or be sensitive to ROS. In this study, we have shown for the first time that TCR cross-
linking induced rapid (within 15 min) generation of both hydrogen peroxide and superoxide
anion, as defined with oxidation-sensitive dyes, selective pharmacologic antioxidants, and
overexpression of specific antioxidant enzymes. Furthermore, the data suggest the novel obser-
vation that superoxide anion and hydrogen peroxide are produced separately by distinct TCR-
stimulated pathways. Unexpectedly, TCR-stimulated activation of the Fas ligand (FasL) pro-
moter and subsequent cell death was dependent upon superoxide anion, but independent of
hydrogen peroxide, while nuclear factor of activated T cells (NFAT) activation or interleukin 2
transcription was independent of all ROS. Anti-CD3 induced phosphorylation of extracellular
signal–regulated kinase (ERK)1/2 required hydrogen peroxide generation but was unaffected
by superoxide anion. Thus, antigen receptor signaling induces generation of discrete species of
oxidants that selectively regulate two distinct redox sensitive pathways, a proapoptotic (FasL)
and a proliferative pathway (ERK).
Key words: T lymphocytes • reactive oxygen species • signal transduction • genes, reporter • 
oxidoreductases
 
Introduction
 
Reactive oxygen species (ROS)
 
*
 
 are generated by all mam-
malian cells as by-products of metabolism or apoptotic sig-
nals and by some cells in host defense response to noxious
stimuli. In general, production of ROS is associated with
deleterious effects in pathophysiologic conditions, includ-
ing inflammatory responses, apoptosis, or ischemia/reper-
fusion (1). In a growing number of systems, however, gen-
eration of ROS is useful and even required by physiologic
systems. Receptor systems as diverse as epidermal growth
factor (EGF), CD40, and angiotensin II induce generation
of intracellular ROS upon ligand binding and the ROS
were necessary for appropriate signal transduction, kinase
activation, and biologic responses associated with receptor
signaling (2–4).
While there is obvious diversity in the immediate signal
transduction pathways linked to receptors such as EGF (a
receptor tyrosine kinase) or angiotensin II (a G protein–
coupled receptor), data suggest that diverse receptors stim-
ulate ROS generation via activation of an intracellular
NADH/NADPH oxidase homologous to that expressed in
inflammatory cells (5, 6). Activation of the oxidase, as in
the respiratory burst of macrophages and neutrophils, leads
to generation of superoxide anion in response to receptor
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Rockville, MD 20855. Phone: 301-738-0468; Fax: 301-517-0344; E-mail:
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*
 
Abbreviations used in this paper:
 
 BHA, butylated hydroxyanisole; CuZn-
SOD, copper/zinc superoxide dismutase; DCFDA, dichlorodihydrofluo-
rescein diacetate; DHE, dihydroethidium; DPI, diphenylene iodonium;
ERK, extracellular signal–regulated kinase; GFP, green fluorescent pro-
tein; MAP, mitogen-activated protein; MnSOD, manganese superoxide
dismutase; NFAT, nuclear factor of activated T cells; RFP, red fluorescent
protein; ROS, reactive oxygen species; TPx, thioredoxin peroxidase. 
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stimulation. However, in these systems, the ROS pro-
duced are not cytotoxic, but are required for mitogen-acti-
vated protein (MAP) kinase family member activation,
gene expression, and/or cell proliferation (3, 4, 7, 8). Al-
though receptor-stimulated generation of superoxide anion
is necessary, it is not sufficient. Signal transduction seems to
require dismutation of superoxide to hydrogen peroxide,
as overexpression of antioxidant enzymes such as catalase
and thioredoxin peroxidase (TPx) could inhibit receptor-
stimulated MAP kinase activation and downstream effects
(3, 7–9).
In T lymphocytes, data does indicate that receptor stim-
ulation can induce ROS generation although there is no
evidence of expression of an NADH/NADPH oxidase
(10). Studies investigating T cell activation and apoptosis
have suggested that T cell mitogens (11, 12), lectins
(ConA; reference 13), anti-CD3 (11, 14), and superanti-
gens (mouse mammary tumor virus [15], Staphylococcal
enterotoxin B, and Staphylococcal enterotoxin A [16])
stimulate ROS generation. Furthermore, by using antioxi-
dants, regulatory roles have been ascribed for ROS in T
cell proliferation and death. Further investigation indicated
that ROS production was selectively required for expres-
sion of functional Fas ligand (FasL) on the surface of anti-
CD3–stimulated T cells in models of activation-induced
cell death (AICD; reference 11).
Thus, this study examines the kinetics and signaling
role(s) of anti-CD3–stimulated ROS generation in mature
T cells. The data suggest that TCR stimulation induces
rapid production of discrete species of oxidants; namely su-
peroxide anion and hydrogen peroxide, via separate path-
ways that can be differentiated using specific antioxidant
enzymes and pharmacologic inhibitors. Beyond this notable
observation, superoxide and hydrogen peroxide also regu-
late distinct TCR-activated signaling pathways. Activation
of ERK was dependent upon TCR-induced hydrogen per-
oxide generation, while FasL promoter activation required
superoxide anion production. Thus, antigen receptor–stim-
ulated ROS generation in T cells serves to regulate a pro-
apoptotic pathway (FasL) and a proliferative pathway
(ERK) that are critical for T cell function and survival.
 
Materials and Methods
 
Chemicals.
 
Dihydroethidium (DHE), dichlorodihydrofluores-
cein diacetate (DCFDA), and 1,2-bis (2-aminophenoxyl) ethane-
N,N,N
 
 
 
,N
 
 
 
–tetraacetic acid-acetoxymethyl ester (BAPTA-AM)
were obtained from Molecular Probes. Manganese (III) tetrakis
4-benzoic acid) porphyrin (MnTBaP), and ebselen were from
Calbiochem. Butylated hydroxyanisole (BHA), diphenylene io-
donium (DPI), PMA, ionomycin, and all other chemicals were
from Sigma-Aldrich. All cell culture supplies were all supplied by
Life Technologies. 2C11 and OKT3 were prepared in house
from hybridoma supernatants by Protein G affinity purification.
Antibodies to phosphorylated p44/42 ERK and pan-specific anti-
ERK1/2 were obtained from Cell Signaling. Antibodies to man-
ganese superoxide dismutase (MnSOD; reference 17) and TPx II
(9) have been described previously, while anti-copper/zinc su-
peroxide dismutase (CuZnSOD) was supplied by UBI, and anti-
 
catalase was obtained from Calbiochem. The luciferase assay sys-
tem was from Promega.
 
Plasmids.
 
Mammalian expression vectors for green fluores-
cent protein (GFP; EGFP-N1) and red fluorescent protein (RFP;
RFP-N1) were supplied by CLONTECH Laboratories, Inc.
Full-length cDNA encoding human CuZnSOD (from American
Type Culture Collection), bovine catalase, and the cDNA for the
chimeric murine CD8-Ig
 
 
 
2a
 
 protein (provided by Dr. Michael
Reth, University of Freiburg, Freiburg, Germany) were sub-
cloned into pcDNA3.1 (Invitrogen). Mammalian expression vec-
tors for TPx II (9) and MnSOD (17) have been described previ-
ously, while those for BCl-x
 
L
 
 and N17 Rac1 were supplied by
Charles Zacharchuk (National Cancer Institute, National Insti-
tutes of Health, Bethesda, MD) and J. Silvio Gutkind (National
Institute of Diabetes and Digestive and Kidney Disease, National
Institutes of Health, Bethesda, MD), respectively. Luciferase re-
porter plasmids containing the minimal FasL promoter and a
16-mer fragment of the FasL promoter containing the egr-2/3
binding site (18) were a gift from Jon Ashwell (National Cancer
Institute, National Institutes of Health, Bethesda, MD). Those
containing the minimal IL-2 promoter and a multimerized nu-
clear factor of activated T cells (NFAT) binding site (19) were
obtained from Charles Zacharchuk (National Cancer Institute,
National Institutes of Health, Bethesda, MD).
 
Cells.
 
The murine T cell hybridoma, 9C127, was a gift from
Dr. David Scott (American Red Cross, Rockville, MD) and was
maintained in RPMI 1640 supplemented with 10% FBS, antibi-
otics, and 50 
 
 
 
M 2-mercaptoethanol (complete medium). Hu-
man peripheral T cell blasts were prepared as described previously
(11). Briefly, human PBMCs were isolated by Ficoll separation
and cultured for 2 d with PMA (10 ng/ml) and Ionomycin (1
 
 
 
g/ml) in complete medium. Cells were washed and grown for
at least 24 h in complete medium supplemented with 10 U/ml
rhIL-2 (Roche Molecular Biochemicals). Complete medium
with rhIL-2 will be referred to as complete medium in studies us-
ing human T blasts.
 
Determination of Anti-CD3–induced ROS Generation.
 
9C127
murine T cell hybridoma or human T blasts (10 
 
 
 
 10
 
6
 
cells/ml)
were precoated with anti-CD3 (2C11 for mouse and OKT3 for
human) at 10 
 
 
 
g/ml for 30 min on ice. Cells were washed, resus-
pended in ice cold complete medium (CM), and maintained on
ice at 10 
 
 
 
 10
 
6
 
 cells/ml. At 15-min intervals, aliquots of cells
were diluted 1:10 into tubes maintained at 37
 
 
 
C containing com-
plete medium with 5 
 
 
 
g/ml rabbit anti–hamster antibody (to
x-link 2C11) or goat anti–mouse (to x-link OKT3). The oxida-
tion sensitive dyes DHE (2 
 
 
 
M) or DCFDA (2 
 
 
 
M) were added
separately to tubes 15 min before harvest. Incubation was termi-
nated by 10-fold dilution with ice cold FACS
 
®
 
 buffer and the
cells were washed before FACS
 
®
 
 analysis. ROS generation was
determined by the increase in DHE or DCFDA fluorescence
upon anti-CD3 stimulation. Stimulated increase in dye oxidation
was calculated as the percentage increase in mean channel fluores-
cence of anti-CD3–stimulated cells over unstimulated cells for
each time point using the following equation: 
 
 
 
 ([MCF
 
(stim)
 
 
 
 
 
MCF
 
(unstim)
 
]/MCF
 
(unstim)
 
) 
 
 
 
 100. Neither cells prebound with
control antibodies (anti-DNP; BD PharMingen), nor cells ex-
posed to anti-CD3 or secondary cross-linking antibody alone
showed evidence of oxidation of either DCFDA or DHE.
To control for potential variations in dye uptake or de-esterifi-
cation of DCFDA in cells stimulated with anti-CD3, the assays
were also performed with oxidized forms of DCFDA; dichloro-
fluorescein or fluorescein diacetate (Molecular Probes). There was
no difference in unstimulated versus anti-CD3–stimulated cells in 
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the staining by these two dyes. The oxidized form of dihydro-
ethidium (ethidium bromide) is relatively membrane impermeant
in live cells, thus was not tested.
In experiments using pharmacologic inhibitors, the cells were
preincubated with drugs while being precoated with anti-CD3 at
4
 
 
 
C. Cells were maintained in the presence of the appropriate
concentration of drug throughout the subsequent incubations.
 
Overexpression of Antioxidants and ROS Generation.
 
9C127 T
cell hybridoma or human T blasts (40 
 
 
 
 10
 
6
 
/ml) were transiently
transfected by electroporation (Gene Pulser; Bio-Rad Laborato-
ries). Expression plasmids for BCl-x
 
L
 
, catalase, CuZnSOD,
N17Rac1, MnSOD, TPx, or an empty vector (Vector Laborato-
ries) were cotransfected with vectors encoding either GFP or RFP
in a 2:1 ratio to ensure that any cell expressing GFP or RFP
would also express the protein of interest. After 16 h incubation,
transfected cells were harvested, counted, and assayed for anti-
CD3–stimulated ROS production as described above. GFP fluo-
rescence was used as a marker to gate on transfected cells in exper-
iments using DHE while RFP fluorescence was used to gate on
transfected cells in experiments with DCFDA. As shown in Fig. 3
C, expression of fluorescent proteins did not affect dye uptake.
 
Western Blot Determination of Protein Overexpression.
 
Overex-
pression of proteins was measured by Western blot analysis essen-
tially as described previously (20). Cells were transiently trans-
fected with expression plasmids as described above except a
plasmid expressing a chimeric murine CD8-Ig
 
 
 
2a
 
 protein (21)
was used as a transfection marker. After incubation for 16 h to al-
low protein overexpression, viable cells were enriched by Ficoll
separation. CD8 positive, productively transfected cells were pu-
rified by magnetic selection using anti-CD8 linked to magnetic
beads (Polysciences). Previous data have indicated that this
method leads to 
 
 
 
95% CD8
 
 
 
 cells. Purified cells were immedi-
ately pelleted and processed for Western blot. Cell pellets were
suspended in lysis buffer (20 mM Tris HCl, pH 7.5; 1% Triton
X-100; 50 mM NaCl; 5 mM EDTA; 10 
 
 
 
g/ml trypsin inhibitor;
10 
 
 
 
g/ml leupeptin; 2 
 
 
 
g/ml aprotinin; 1 mM phenylmethane-
sulphonyl fluoride; and 10 
 
 
 
g/ml pepstatin), and supernatants
stored at –80
 
 
 
C. Equal amounts of protein (50 
 
 
 
g/sample) were
separated by SDS-PAGE and blotted onto PVDF membranes,
which were blocked with PBS plus 1% BSA. Primary antibodies
were incubated with blots (50 mM Tris HCl, pH 7.5; 150 mM
NaCl; 0.1% BSA; 0.05% Tween-20) for 2 h at 25
 
 
 
C, all using 1
 
 
 
g/ml antibody. Blots were washed in the same buffer and incu-
bated with the appropriate horseradish persoxidase (HRP)-conju-
gated secondary antibody and bands visualized by enhanced
chemoluminescence (ECL; Pierce Chemical Co.).
 
Luciferase Reporter Gene Expression.
 
9C127 murine T cell hy-
bridoma or human T blasts were transfected as above except that
expression plasmids encoding BCl-x
 
L
 
, catalase, CuZnSOD, Mn-
SOD, TPx, or an empty vector (Vector Laboratories) were
cotransfected with luciferase reporter vectors (pGL3; Promega)
containing the indicated promoters or cDNA. The transfected
cells were cultured for 16 h in complete medium, counted, and
stimulated in plates precoated with anti-CD3 for 6 h. The cells
were then harvested, lysed, and supernatants assayed for luciferase
activity as per manufacturers instructions using a plate chemilu-
minometer (Dynatech). Fold increase in luciferase activity was
used as a measure to assess the effect of overexpressed proteins on
FasL promoter activity and cotransfected 
 
 
 
-galactosidase (assayed
with Galacto-Light Plus kit; Tropix) was used to normalize
transfection efficiency.
 
Determination of Cell Death and Apoptosis.
 
Apoptosis/cell
death was induced in 9C127 T cells by incubation on anti-CD3
(2C11) coated plates (5 
 
 
 
g/ml). Anti-CD3–stimulated apoptosis
was assessed after 16 h by staining cells with propidium iodide
(PI; 25 
 
 
 
g/ml), RNase, and saponin (0.2%) for 60 min at room
temperature and then quantitating hypodiploid cells by flow cy-
tometry. Cell death was measured in GFP-transfected cells that
had been cultured for 16 h after transfection to allow protein ex-
pression and then incubated a further 24 h on immobilized anti-
CD3 or in the absence of stimulation. Harvested cells were resus-
pended in FACS
 
®
 
 buffer containing 5 
 
 
 
g/ml PI and analysis of
GFP
 
 
 
 and PI
 
 
 
 cells was performed by flow cytometry. GFP
 
 
 
cells were defined as those cells with fluorescence in the top 2
deciles on a log plot.
 
Immunohistochemical Staining for Activated ERK.
 
9C127 mu-
rine T cell hybridoma or human T blasts were transfected as
above using GFP as a transfection marker. After 16 h incubation,
cells were stimulated with anti-CD3 as for ROS generation.
However, instead of pulsing with oxidation sensitive dyes, cells
were fixed with 4% paraformaldehyde for 30 min on ice and then
washed and incubated for 20 min on ice in ice-cold 80% MeOH.
The cells were then washed and cryopreserved at –80
 
 
 
C for later
use. Cryopreservation did not appear to affect cells as measured
by GFP staining of cells. The cryopreserved cells were thawed
and immunochemically stained for MAP kinase activation essen-
tially as described previously (22). Cells were washed with wash
buffer (PBS containing 1% BSA and 0.1% Triton X-100) and
blocked with 2% nonfat dry milk at room temperature for 30
min. After a wash, primary antibody to phospho-ERK or pan-
ERK was added and incubated on ice for 2 h. The cells were then
washed, further stained with biotinylated secondary antibody
(Southern Biotechnology Associates, Inc.) and streptavidin-allo-
phycocyanin (APC; BD PharMingen), and APC staining in
GFP
 
 
 
 cells was determined by FACS
 
®
 
 analysis using a FACSCal-
ibur™ flow cytometer (Becton Dickinson). Staining and wash
conditions were developed such that a nonspecific rabbit anti-
DNP antibody (provided by Dr. David Segal, National Cancer
Institute, National Institutes of Health, Bethesda, MD) exhibited
minimal staining over unstained control cells. Specificity of stain-
ing was determined using a phosphorylated ERK protein sup-
plied by manufacturers to competitively block specific staining,
and by using the MEK1 inhibitor PD98059 (Calbiochem) to
block anti-CD3–induced ERK activation.
 
Statistics.
 
Tests for statistical significance were done using a
paired, two-tailed Student’s 
 
t
 
 test. Data were considered signifi-
cantly different if 
 
P
 
 
 
 
 
 0.05.
 
Results
 
TCR-stimulated ROS Production.
 
The kinetics of anti-
CD3–stimulated ROS production in the murine T cell hy-
bridoma 9C127 were measured using the cell permeant,
oxidation sensitive dyes DCFDA or DHE. These dyes are
nonfluorescent until oxidized by ROS and an increase in
fluorescence of DCFDA (Fig. 1 A) indicates oxidation by
peroxides, peroxynitrite, and/or hydroxyl radical (23),
while DHE is selectively oxidized by superoxide anion (24)
to the fluorescent product ethidium bromide (Fig. 1 B).
Thus, DCFDA oxidation was measured as early as 15 min
after TCR activation and was maintained throughout the
time points monitored (Fig. 1 C). When these experiments
were performed using preoxidized forms of DCFDA (fluo-
rescein diacetate or dichlorofluorescein), anti-CD3 stimula- 
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tion induced no alterations in fluorescence (data not shown)
indicating that the observed changes in DCFDA signal were
not due to altered uptake, sequestration, or de-esterification
of the dye. Using DHE as a selective probe for superoxide
anion, anti-CD3–stimulated oxidation of DHE was ob-
served only at 45 and 60 min (Fig. 1 C). Thus, the data are
consistent with anti-CD3–stimulated intracellular genera-
tion of distinct species of oxidants with different kinetics.
 
Selective Antioxidants Regulate TCR-stimulated ROS Gen-
eration.
 
To further characterize the ROS generated upon
TCR stimulation in 9C127 cells, antioxidants were used as
scavengers of selective species of oxidants. In all experi-
ments DCFDA oxidation was measured 15 min after anti-
CD3 cross-linking, while DHE oxidation was determined
at 60 min. The SOD mimetic MnTBaP, which has been
shown to possess both SOD and peroxidase activity in vitro
Figure 1. Anti-CD3–stimulated gen-
eration of ROS in 9C127 murine T cell
hybridoma. (A) Representative FACS®
profile for anti-CD3–induced DCFDA
oxidation at 15 min with unstimulated
cells (dashed lines) and anti-CD3–stimu-
lated cells (filled profile). (B) Represen-
tative FACS® profile for anti-CD3 stim-
ulated DHE oxidation at 60 min with
unstimulated cells (dashed lines) and
anti-CD3–stimulated cells (filled pro-
file). (C) Kinetics of DCFDA/DHE ox-
idation in 9C127 cells. 9C127 cells were
stimulated with anti-CD3 as described
in Materials and Methods and the oxida-
tion of DCFDA ( ) and DHE ( ) was
determined by FACS® analysis. The
data are expressed as the percent stimu-
lated increase in mean channel fluores-
cence of DCFDA/DHE over unstimu-
lated controls and represent the average
of at least five separate experiments ( 
SEM). *Anti-CD3–stimulated DCFDA
oxidation is significantly different from
unstimulated controls (P     0.05).
#Anti-CD3–stimulated DHE oxidation
is significantly different from unstimu-
lated controls (P   0.05).
Figure 2. Effect of ROS scaven-
gers and chemical inhibitors of
ROS. Anti-CD3–induced ROS
generation was determined as de-
scribed in Materials and Methods.
DCFDA oxidation ( ) was deter-
mined after 15 min and DHE oxida-
tion ( ) after 60 min stimulation
with anti-CD3 in the presence or
absence of titrated concentrations of
(A) MnTBaP, (B) ebselen, (C)
BHA, (D) diphenylene iodonium
(DPI), or (E) BAPTA-AM. The data
are normalized to anti-CD3–induced
DCFDA/DHE oxidation in the
absence of drug and are expressed
as percentage change in anti-CD3–
stimulated fluorescence compared
with cells exposed to drug alone.
The data represent the average of at
least three experiments (  SEM).
*Anti-CD3–stimulated DCFDA ox-
idation is significantly different from
that in the absence of drug (P   
0.05). #Anti-CD3–stimulated DHE
oxidation is significantly different
from that in the absence of drug
(P   0.05). 
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(25), inhibited oxidation of both DCFDA and DHE in a
dose-dependent manner (Fig. 2 A). In contrast, the hy-
droxyl radical scavenger BHA (Fig. 2 B), and the glu-
tathione peroxidase (GPx) mimetic ebselen (Fig. 2 C) only
inhibited DCFDA oxidation while having a limited effect
on TCR-stimulated DHE oxidation. The data suggest that
hydrogen peroxide or some derivative thereof (as detected
by DCFDA oxidation) is rapidly produced after TCR acti-
vation and that the early hydrogen peroxide generation is
not required for the later generation of superoxide anion
(as measured by DHE oxidation).
Receptor-stimulated generation of superoxide anion
was previously shown to be sensitive to DPI, an inhibitor
of many flavoprotein dehydrogenases. Anti-CD3–stimu-
lated DHE oxidation was also blocked by DPI in a dose-
dependent manner (Fig. 2 D). Nevertheless, DCFDA oxi-
dation was completely insensitive to even high concentra-
tions of DPI, suggesting that superoxide anion generation
was not necessary to produce the oxidants that oxidize
DCFDA. Oxidation of both dyes, however, was depen-
dent upon TCR-stimulated calcium flux, as the intracel-
lular calcium chelator, BAPTA-AM potently inhibited
anti-CD3–induced increases in both DHE and DCFDA
fluorescence (Fig. 2 E). In separate experiments, it was
found that BAPTA-AM does not scavenge either hydro-
gen peroxide or superoxide anion when added exoge-
nously to cells (not shown).
 
Overexpression of Specific Antioxidant Enzymes.
 
As phar-
macologic antioxidants, such as MnTBaP, may not target
specific ROS (25), overexpression of specific antioxidant
enzymes was used to define TCR-stimulated production of
ROS in 9C127 cells. Overexpression of MnSOD (mito-
 
chondrial) and CuZnSOD (cytosolic) were used to specifi-
cally scavenge superoxide anion. Similarly, catalase (peroxi-
somal) and thioredoxin peroxidase II (TPx; cytosolic) were
used to specifically target hydrogen peroxide. Cells were
cotransfected with vectors encoding the antioxidant en-
zymes and with one expressing GFP which was used as a
transfection marker. Using flow cytometric sorting for
GFP
 
 
 
 cells followed by Western blot analysis, it was found
that high levels of the desired protein were achieved in cells
expressing the marker protein (GFP; not shown). Thus, vi-
able transfected cells were defined by both forward light
scatter (FSC) versus side scatter (SSC) (R1; Fig. 3 A) and
GFP fluorescence (R2; Fig. 3 B), and DHE oxidation was
measured in these cells following anti-CD3 stimulation for
60 min (Fig. 3 D).
Stimulation via anti-CD3 cross-linking induced a similar
level of DHE oxidation in vector transfected cells as in
nonelectroporated cells (not shown). However, upon over-
expression of MnSOD or CuZnSOD, anti-CD3–induced
DHE oxidation was completely abrogated while catalase or
TPx had no effect (Fig. 3 E). This supports the hypothesis
that superoxide anion is required for DHE oxidation and
also reinforces the antioxidant data in that scavengers of
hydrogen peroxide did not affect anti-CD3–stimulated su-
peroxide generation.
In an effort to further elucidate potential sources of
TCR-induced ROS generation, BCl-x
 
L
 
 was overex-
pressed, as BCl-2 family members have been shown to reg-
ulate mitochondrially derived ROS under basal conditions
and in apoptotic cells (26). In addition, dominant negative
Rac1 (N17 Rac1) overexpression has been shown to in-
hibit receptor-stimulated ROS production and has been
Figure 3. Effect of protein
overexpression on anti-CD3–
stimulated DHE oxidation in
9C127 cells. 9C127 cells were
transfected with the indicated
vectors at a 2:1 ratio with one
encoding GFP as a transfection
marker. After 16 h incubation,
anti-CD3–induced DHE oxida-
tion was measured as described
in Materials and Methods. (A)
“Normal sized” cells as defined
by R1 in the FSC/SSC plot
were analyzed. (B) Representa-
tive GFP staining profile. GFP
expressing, productively trans-
fected cells were defined by R2.
(C) Relationship of GFP fluores-
cence to basal DHE staining in-
dicating that expression of GFP
did not affect dye uptake. (D)
Representative DHE profile of
“normal sized,” GFP  cells with
unstimulated cells (dashed lines)
and anti-CD3–stimulated cells
(filled profile). (E) Effect of pro-
tein overexpression on anti-CD3–induced DHE oxidation in 9C127 cells. DHE oxidation was determined after 60 min anti-CD3 stimulation in “normal
sized,” GFP  cells and was normalized to Vector control. The data represent the average of at least four separate experiments (  SEM). #Significantly
different from that measured in Vector transfected samples (P   0.05). 
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proposed to act via inhibition of an NADPH oxidase (5).
Overexpression of both proteins exerted a potent inhibitory
effect on anti-CD3–induced DHE oxidation (Fig. 3 E).
 
TCR-stimulated ROS Production in Human T Blasts.
 
To
extend these observations to primary T cells, anti-CD3–
induced ROS generation was also measured in activated
peripheral human T blasts. Kinetics of anti-CD3 stimulated
oxidant production demonstrated DCFDA oxidation as
early as 15 min and, as in 9C127 cells, was sustained for all
time points assayed (Fig. 4 A). In contrast to the results us-
ing the T cell hybridoma, anti-CD3–induced DHE oxida-
tion was also observed after 15 min stimulation and this was
maintained throughout the assay. Thus, anti-CD3 stimula-
tion of primary activated human T cell blasts also resulted
in rapid oxidation of both DHE and DCFDA, albeit at
slightly different kinetics than in the murine hybridoma.
Overexpression of antioxidant enzymes in human T
blasts was also used to characterize the species of oxidants
generated upon anti-CD3 stimulation. Overexpression of
MnSOD and CuZnSOD both completely blocked anti-
CD3–induced DHE oxidation, while catalase and TPx had
little or no inhibitory effect (Fig. 5 B). These data are con-
sistent with that observed in 9C127 cells and are supported
by the observation that BCl-x
 
L
 
 also completely inhibited
TCR-stimulated DHE oxidation. Western blot analysis of
transfected cells indicated that there was significant overex-
pression of proteins in productively transfected cells, which
were purified based upon expression of the transfection
marker (Fig. 4 C).
The effects of antioxidant enzyme overexpression on
anti-CD3–induced DCFDA oxidation was also determined
in the human T blasts. As the emission spectrum of GFP
and DCFDA overlap, RFP was used as a cotransfection
marker, and DCFDA oxidation was measured in RFP
 
 
 
cells in a manner analogous to that described with GFP and
DHE (Fig. 4 B). As anticipated, overexpression of catalase
or TPx completely blocked anti-CD3–induced DCFDA
oxidation. Increased levels of CuZnSOD or MnSOD,
which would convert any superoxide to hydrogen perox-
ide, did not significantly affect DCFDA oxidation. Bcl-x
 
L
 
overexpression did not affect TCR-stimulated DCFDA
oxidation, further supporting the hypothesis that TCR-
stimulated superoxide production was not necessary for the
parallel generation of hydrogen peroxide or hydroxyl radi-
cal. Furthermore, incubation of human T blasts with DPI
(10 
 
 
 
M) also inhibited DHE oxidation (7.2 
 
 
 
 3.1% of that
observed at 15 min in the absence of drug) while having
little effect on DCFDA oxidation (89.7 
 
 
 
 5.4% of that ob-
served at 15 min in the absence of drug). Thus, as in the
murine T cell hybridoma, TCR stimulation of human T
blasts induces rapid production of both superoxide anion
and hydrogen peroxide apparently via distinct pathways.
 
Requirement for ROS in FasL Gene Expression.
 
As previ-
ous results suggested that ROS were necessary for surface
Figure 4. Anti-CD3–induced
ROS generation in human T
blasts. (A). Kinetics of anti-CD3–
stimulated DCFDA/DHE oxida-
tion human T blasts. Human T
blasts were stimulated with anti-
CD3 as described in Materials and
Methods and the oxidation of
DCFDA ( ) and DHE ( ) was
determined by FACS® analysis.
The data are expressed as the per-
cent stimulated increase in mean
channel fluorescence of DCFDA/
DHE over unstimulated controls
and represent the average of at
least five separate experiments ( 
SEM). (B) Effect of protein over-
expression on DCFDA/DHE oxi-
dation in human T blasts. Human
T blasts were transfected with
empty vector (Vector) or expres-
sion vectors encoding BCl-xL, cat-
alase, CuZnSOD, MnSOD, or
TPx at a 2:1 ratio with one encod-
ing GFP or RFP as a transfection
marker. After 16 h incubation,
anti-CD3–induced DCFDA
(hatched bars) or DHE (closed
bars) oxidation was measured as
described in Materials and Methods and the legend to Fig. 3. DHE oxidation was measured in GFP  cells while DCFDA oxidation was measured in
RFP-transfected cells, both after 15 min anti-CD3 stimulation and was normalized to Vector control. The data represent the average of at least four sep-
arate experiments (  SEM). *Significantly different from that in Vector transfected samples (P   0.05). #Significantly different from that in Vector trans-
fected samples (P   0.05). (C) Western blot confirmation of protein overexpression. Human T blasts were transiently transfected with the indicated
mammalian expression vectors in twofold excess over a marker plasmid expressing a chimeric CD8-Ig 2a protein. After 16 h incubation, viable CD8 
cells were purified by magnetic bead selection. Protein overexpression was determined in positively selected cells by Western blot as described in Materi-
als and Methods.65 Devadas et al.
expression of functional FasL (11), the potential role(s) of
superoxide anion and/or peroxide in FasL expression were
evaluated using a luciferase reporter plasmid driven by the
FasL promoter. Anti-CD3 stimulation of 9C127 cells trans-
fected with the FasL promoter luciferase construct induced
a fourfold induction of reporter gene activity (Fig. 5 A).
Overexpression of either MnSOD or CuZnSOD potently
inhibited activation of the FasL promoter, as did the other
protein that selectively inhibited DHE oxidation, BCl-xL
(Fig. 5 A). Conversely, neither catalase nor TPx had an in-
hibitory effect on anti-CD3–mediated activation of the
FasL promoter. The same profile of inhibition was ob-
tained using the FasL promoter construct in the human T
blasts (Fig. 5 A).
Multiple reports have implicated NFAT transactivation
in either directly (27–29) or indirectly (18, 30) regulating
FasL transcription. In addition, previous results indicated
that anti-CD3–induced IL-2 secretion could be pharmaco-
logically distinguished from FasL transcription in a murine
T cell hybridoma (11). Thus, the effects of the antioxidant
enzymes were measured using reporter constructs linked to
the IL-2 promoter and one containing consensus binding
sites for the transcription factor, NFAT. In the 9C127 cells,
there was no effect of overexpression of any of the antioxi-
dant enzymes on anti-CD3–stimulated transcription driven
by the IL-2 promoter or NFAT (Fig. 5 B). In human T
blasts, anti-CD3–induced surface expression of the early ac-
tivation marker, CD69, was also not inhibited in cells trans-
fected with the antioxidant enzymes (not shown). Thus,
TCR-stimulated generation of superoxide anion selectively
regulates gene and surface protein expression in T cells.
Furthermore, regulation of FasL expression by superoxide
anion does not appear to be through effects on NFAT.
Role of Superoxide Anion in Anti-CD3–induced Cell
Death. To test the significance of this selective role of
ROS, the functional role of superoxide anion in anti-
CD3–stimulated apoptosis and cell death was determined.
Previous studies using antioxidants had suggested that ROS
generation was required for anti-CD3–stimulated apoptosis
of mature T cells (11). Incubation with the SOD mimetic,
MnTBaP, at a concentration (50  M) that blocked DHE
oxidation, almost completely blocked anti-CD3–stimulated
apoptosis of 9C127 cells (Fig. 6 A). This suggests that su-
peroxide anion is necessary for AICD, but as MnTBaP also
has peroxidase activity (Fig. 2), additional experiments in
cells overexpressing CuZnSOD were performed to solidify
a role for superoxide. 9C127 cells were cotransfected with
CuZnSOD and GFP as above and after 16 h incubation to
allow protein expression the cells were stimulated for 24 h
on immobilized anti-CD3. As loss of membrane integrity
(cell death) will result in loss of GFP within the cell, the
expression of GFP was used as an indicator of whether
overexpression of a cotransfected protein would lead to a
survival advantage. In vector-transfected cells, anti-CD3
stimulation led to  70% death of total cells (Fig. 6 B) or
60% of those cells detected as GFP  (Fig. 6 C). The same
data were obtained when an irrelevant protein ( -galactosi-
dase) was overexpressed (not shown). In cells transfected
with CuZnSOD, anti-CD3–induced death of the total cell
population was similar to that in the vector transfected
samples. However, the stimulated death of those cells pro-
ductively transfected with CuZnSOD (GFP  cells) was sig-
nificantly inhibited (only 21% cell death; Fig. 6 C), suggest-
ing that cells overexpressing CuZnSOD were selectively
resistant to anti-CD3–induced cell death. These data sug-
gest that the inhibition of FasL expression by SOD overex-
Figure 5. Effect of protein over-
expression on anti-CD3–induced
reporter plasmid activation. (A)
9C127 cells (solid bars) or human
T blasts (hatched bars) were trans-
fected with empty vector (Vector)
or expression vectors encoding
BCl-xL, catalase, CuZnSOD, Mn-
SOD, or TPx at a 2:1 ratio with
one containing a 0.5 kb portion of
the FasL promoter inserted into a
luciferase reporter vector. (B)
9C127 cells were transfected with
the same vectors at a 2:1 ratio with
luciferase reporter vectors contain-
ing the minimal IL-2 promoter
(hatched bars) and a multimerized
NFAT binding site (open bars).
Anti-CD3–stimulated luciferase
activity in cell lysates was measured
by chemoluminescence as de-
scribed in Materials and Methods.
Data are expressed as fold induc-
tion of luciferase activity over un-
stimulated and represents the aver-
age of at least four experiments.
*Significantly different from Vec-
tor transfected controls (P   0.05).66 TCR-stimulated Generation of Superoxide and Hydrogen Peroxide
pression is also reflected by an inhibition of anti-CD3–
induced cell death. Overexpression of TPx also induced a
slight decrease in the death of GFP  cells (Fig. 6 C), al-
though it was not significantly different from the death of
vector transfected cells.
Regulation of ERK Activation by ROS Generation. Fur-
ther analysis of the requirement for ROS in anti-CD3–
stimulated signal transduction focused upon the MAP ki-
nase family, which have been shown to be sensitive to both
exogenous and endogenously generated ROS (31, 32). To
measure MAP kinase activation in the transiently trans-
fected cell systems, a protocol for immunohistochemical
staining of cells with an antibody specific for phosphory-
lated ERK1/2 (22) was adapted to lymphocytes transfected
with GFP. Antibody specificity was demonstrated by com-
petition of binding with a phosphorylated ERK protein
supplied by the manufacturers, and by incubation with the
MEK1/2 inhibitor PD98059 (Fig. 7 A) during anti-CD3
Figure 6. Functional role for superoxide in anti-CD3–stimulated cell death. (A) 9C127 cells were unstimulated (hatched bars) or incubated on immo-
bilized anti-CD3 (solid bars) for 16 h in the presence or absence of the SOD mimetic MnTBaP. Cells were harvested and apoptosis (hypodiploid cells)
was measured after staining with propidium iodide by flow cytometry as described in Materials and Methods. The data are expressed as the percent apop-
totic cells and represent the average of three separate experiments   SEM. *Significantly different from untreated controls (P   0.002). (B and C) 9C127
cells were transfected with empty vector (Vector) or an expression vector encoding CuZnSOD or TPx at a 2:1 ratio with one encoding GFP as a trans-
fection marker. After 16 h culture, cells were incubated for 24 h further on immobilized anti-CD3 (solid bars) or in the absence of stimulation (hatched
bars). The percent total viable (PI ) cells (B) and those expressing GFP (C) were quantitated by flow cytometry. Anti-CD3–stimulated death of productively
transfected (GFP ) viable cells for vector transfected cells was 58.7   6.3%, while that in CuZnSOD-transfected cells was 21.1   7.4% (significantly differ-
ent from vector control; P   0.05) and in TPx overexpressing cells it was 39.7   4.3% (not significantly different from vector control; P   0.2). The data
represent the average of three separate experiments   SEM. *Significantly different from unstimulated controls (P   0.01); #Significantly different from
unstimulated controls (P   0.05); †Not significantly different from unstimulated controls (P   0.1).
Figure 7. Anti-CD3–stimulated
ERK phosphorylation. (A) Anti-
CD3–induced phosphorylation of
ERK was measured after 5 min stim-
ulation in GFP  9C127 cells. Stimu-
lation was performed in the presence
(dashed line) or absence (heavy
solid line) of the MEK1 inhibitor
PD098059 by immunohistochemical
staining using a phospho-specific an-
tibody for ERK1/2 as described in
Materials and Methods. Staining was
quantitated by flow cytometry after
stain with biotin goat anti–rabbit and
streptavidin-APC. Profiles of un-
stimulated cells (solid line) and anti-
CD3–stimulated cells stained with
secondary antibody alone (dotted
line) or unstained (shaded profile) are
also shown. Staining with pan-anti-
ERK1/2 was not altered in any sam-
ple (not shown). (B) 9C127 cells
were transfected with empty vector
(Vector) ( ) or expression vectors encoding CuZnSOD ( ) or TPx ( ) at a 2:1 ratio with one encoding GFP as a transfection marker. The data repre-
sent the anti-CD3–stimulated fold increase in mean APC fluorescence in GFP  cells and are representative of at least three separate experiments. *Sig-
nificantly different from unstimulated controls (P   0.05). #Significantly different from Vector-transfected samples (P   0.05).67 Devadas et al.
stimulation. Both approaches completely blocked anti-
CD3–induced increases in staining and total ERK, as visu-
alized with a pan-specific anti-ERK antibody, was un-
changed under all conditions analyzed (not shown). In
vector-transfected 9C127 cells, anti-CD3 induced ERK
phosphorylation peaked at 5 min, and decreased to back-
ground after 2 h (Fig. 7 B). Cells transfected with TPx dis-
played no anti-CD3–induced ERK activation, while phos-
pho-ERK staining was slightly decreased in cells
overexpressing CuZnSOD. Similar inhibition of anti-
CD3–induced phospho-ERK staining in TPx overexpress-
ing cells was also observed in human T blasts (not shown).
Thus, anti-CD3–stimulated ERK phosphorylation is selec-
tively sensitive to hydrogen peroxide generation.
Discussion
In this study, antigen receptor signaling of mature T cells
has been shown to stimulate discrete generation of both
superoxide anion and hydrogen peroxide by pathways dis-
tinguishable using pharmacologic and molecular tools. To
our knowledge, this is the first demonstration of such a di-
chotomy in receptor-stimulated ROS production. In addi-
tion to this novel observation, the results suggest that the
two species of oxidants produced after TCR stimulation
regulate the activation of distinct signal transduction path-
ways. Thus, the data suggest that superoxide anion targets a
pro-death signal in mature T cells (FasL expression), while
hydrogen peroxide production regulates what has been
typically characterized as a pro-life or proliferative signal
(ERK activation).
Previous data had suggested that T cell activation and
TCR signal transduction may involve ROS generation
(11), but did not address the potential role(s), the species of
oxidant, nor the kinetics of generation. Data from the
present study support the hypothesis that TCR signaling
rapidly activates 2 distinct pathways of ROS generation.
Hydrogen peroxide production in the 9C127 cells mea-
sured via DCFDA oxidation preceded superoxide anion
generation, suggesting that TCR-induced hydrogen per-
oxide was not derived from dismutation of superoxide
anion. Furthermore, the selective ability of BCl-xL and
DPI to inhibit superoxide generation without effect on
DCFDA oxidation supports the hypothesis of discrete
pathways for TCR-stimulated generation of superoxide
and hydrogen peroxide. Similarly, early generation of hy-
drogen peroxide was not required for superoxide genera-
tion, as increased levels of catalase or TPx did not greatly
affect DHE oxidation, enhancing the distinction between
the two signaling pathways.
A recent report has suggested that TNF signaling can in-
duce two distinguishable pathways of oxidant generation
(33), where one is sensitive to overexpression of N17 Rac1
and is antiapoptotic and the other is potentially derived
from mitochondria and regulates a proapoptotic pathway.
In another study, mitochondrially derived ROS generation
has been suggested to play a regulatory role in cell function
and signaling and affect activation of a proapoptotic MAP
kinase, JNK1 (34). In the current study, the effects of
BCl-xL overexpression suggest a potential role for mito-
chondria in superoxide generation, but much more experi-
ments are required to address this hypothesis.
PDGF, angiotensin II, or IL-1 have been proposed to
induce generation of superoxide anion, which was inhib-
ited by overexpression of a DN-Rac1 (N17 Rac1) or incu-
bation with DPI (3, 35). These and other reports have led
to the hypothesis that an NADPH/NADH oxidase is a
source of receptor initiated ROS production (6, 36). N17
Rac1 and DPI also potently inhibited TCR-stimulated su-
peroxide generation in the current study, but it is not clear
that T lymphocytes express an oxidase capable of this pro-
duction. We are currently investigating whether a form of
this oxidase is expressed in T cells as has been shown in B
lymphocytes (37).
Given that superoxide can be and is rapidly converted to
hydrogen peroxide in many cell systems, it was surprising
that TCR signals activated a separate pathway that directly
leads to hydrogen peroxide production. The mechanism by
which TCR stimulation induces hydrogen peroxide pro-
duction in the absence of superoxide is unclear, but subcel-
lular localization or perhaps the prerequisite of some intra-
cellular signaling event may control the generation of distinct
ROS. This separation in time and/or space may limit or
change the redox sensitive targets for these discrete reactive
oxygen species (i.e. phosphatases, GTP-binding proteins, or
protein kinases [PKC, JNK, src]; references 38–40).
Figure 8. Proposed scheme for TCR-stimulated ROS generation.
TCR signaling induces both hydrogen peroxide (H2O2) and superoxide
(O2
  in a calcium dependent manner in pathway(s) independent of
NFAT activation. Hydrogen peroxide production, from an unknown
source, regulates ERK activation. Superoxide anion may be derived from
an NADH/NADPH oxidase and is required for FasL promoter activation.68 TCR-stimulated Generation of Superoxide and Hydrogen Peroxide
MAP kinase activation is a common target of exogenous
or endogenously generated ROS (31, 32). Indeed, Hunt
and colleagues suggested that mitogen-induced ERK2 acti-
vation was redox sensitive in T cells (41). The current
study suggests that hydrogen peroxide regulates ERK phos-
phorylation, and we are currently pursuing the mechanism
by which this occurs.
Exogenous oxidants and redox active substances (che-
motherapeutic agents, MAP kinase activation, H2O2) can
regulate FasL gene expression in the absence of TCR stim-
ulation (42–44). These effects were mapped to sites both
within and outside of the –511 bp region that has been
proposed to regulate antigen-stimulated FasL expression
(18). Thus, although TCR-induced ROS generation may
also affect FasL transcription at upstream sites, the current
data suggest that superoxide anion is required for TCR-
mediated control of FasL expression within the minimal
promoter. The minimal promoter contains a nuclear factor
(NF)- B site (45, 46) and 2 potential AP-1 sites (42, 47)
that may be redox sensitive. Faris et al. have suggested that
active MEKK1-induced binding of a jun/ATF-2 het-
erodimer at –330 bp (42), and it has been suggested that
JNK-mediated jun activation is important for FasL expres-
sion (48). We are currently assessing if these transcription
factors/enzymes are targets of TCR-stimulated superoxide
anion production.
It does not appear that activation of NFAT, which has
been proposed to be a key regulator of FasL transcription
(27, 29), is modulated by superoxide anion. One means by
which NFAT has been proposed to regulate FasL expres-
sion indirectly, is through control of TCR-induced expres-
sion of the egr family of transcription factors (18, 30). The
egr-family of transcription factors have been proposed to
directly transactivate FasL expression (18, 49) and reports
suggest that at least egr-1 activation is redox sensitive (50).
However, in 9C127 cells, transcriptional activation driven
by the 16 mer egr-2/3 binding site of the FasL promoter
(FLRE) (at –214 to –207) identified by Mittlestadt et al.
(18) was not affected by overexpression of antioxidant en-
zymes (data not shown).
While receptor-stimulated generation of superoxide an-
ion has precedence, utilization of superoxide for regulation
of TCR-mediated FasL expression was unexpected. In sys-
tems of receptor-stimulated generation of superoxide an-
ion, in general it has been shown that hydrogen peroxide,
derived from dismutation of the superoxide anion and sen-
sitive to catalase or peroxidase, were the relevant oxidant
species that regulated signaling (8). Although the immedi-
ate target regulated by superoxide is unknown, the bio-
chemical effects of superoxide are often mediated through
effects on iron-sulfur (4Fe-4S) clusters (51). Examples of
this are the superoxide-mediated inactivation of aconitase
(52) or the regulation of the iron response binding protein
(IBP; reference 53). Superoxide also reacts avidly with ni-
tric oxide (NO) to form peroxynitrite. We have previously
demonstrated a role for NO in anti-CD3–induced death of
mature T cells (20). In addition, anti-CD3 stimulated for-
mation of nitrotyrosine, which may be formed upon per-
oxynitrite production (20, 54). Thus, an important mecha-
nism for superoxide may be based on its rapid reaction
with NO.
Recent studies from Marrack and colleagues have sug-
gested that superantigen-induced death of lymphocytes in
vivo requires generation of ROS and appears to be inde-
pendent of Fas/FasL interactions (16). It may be that super-
antigen stimulates similar signaling mechanisms to induce
ROS generation at greater levels than anti-CD3 and that
this level of oxidants directly induces cell death. Our results
suggest that antioxidants can also regulate anti-CD3–
induced cell death, perhaps via an alternative mechanism.
Therefore, depending upon the stimulus, receptor stimu-
lated ROS generation can regulate early signal transduction
steps and/or sensitivity to death.
Thus, in this study, stimulation via the TCR was shown
to induce generation of ROS that served to regulate signal
transduction in T lymphocytes. The results suggest that
TCR utilizes distinct biochemical pathways to yield pro-
duction of two discrete species of oxidants, superoxide an-
ion and hydrogen peroxide (Fig. 8). These ROS, in turn,
selectively regulate independent signaling pathways that
can affect cell death decisions (FasL) or proliferative re-
sponses (ERK). Interestingly, it has recently been suggested
that exposure to mild oxidative stress can enhance TCR-
stimulated activation of MAP kinases and IL-2 transcription
(55), and that synovial fluid T cells isolated from arthritic
joints display redox-dependent alterations in signaling
pathways (56). This suggests that there are redox sensitive
pathways in T cells that may be altered by exposure to ex-
ogenous oxidative stress, as may be encountered in disease
states such as AIDS or arthritis. The results of this study
may suggest that T cells generate their own endogenous
oxidative stress to regulate similar pathways.
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